Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
Abstract Introduction The availability of anti-amyloid therapy for mild cognitive impairment (MCI) due to Alzheimer’s disease and mild Alzheimer’s dementia (AD) has underscored the need for realistic estimates of the population with AD/MCI within the healthcare system to assure adequate preparedness...
Saved in:
Main Authors: | Haixin Zhang, Amir Abbas Tahami Monfared, Quanwu Zhang, Lawrence S. Honig |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-12-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-024-00695-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality of Life in Mild Cognitive Impairment and Mild Dementia Associated with Alzheimer’s Disease: A Systematic Review
by: Joanna Campbell, et al.
Published: (2024-11-01) -
Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01) -
Functional and effective EEG connectivity patterns in Alzheimer’s disease and mild cognitive impairment: a systematic review
by: Elizabeth R. Paitel, et al.
Published: (2025-02-01) -
Glymphatic system clearance and Alzheimer’s disease risk: a CSF proteome-wide study
by: Natalia Cullell, et al.
Published: (2025-01-01) -
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer’s disease
by: Xiaoya Feng, et al.
Published: (2025-01-01)